A Neuraxpharm é proprietária e opera a Neuraxpharm Pharmaceuticals, uma empresa de produção global com sede em Espanha. Emprega mais de 300 pessoas que desenvolvem e fabricam formas de dosagem acabadas (FDF), principalmente formas de dosagem orais sólidas, para o Grupo e para outras empresas farmacêuticas a nível nacional e internacional. Oferecemos também um serviço completo de fabrico de produtos farmacêuticos FDF personalizados, com base nos nossos próprios desenvolvimentos.
Aqui pode encontrar mais informações sobre a nossa Declaração de informações não financeiras.
Neuraxpharm Pharmaceuticals plant specialises in the development and manufacturing of oral solid and sterile forms, mainly in the CNS area. Its portfolio also includes antiemetic, anti-infective, cardiovascular, pain and respiratory products.
Neuraxpharm Pharmaceuticals highly flexible approach and extensive experience have enabled it to cement its place as a reliable partner for large national and international third-party laboratories.
It offers contract manufacturing services for fast dissolving (orodispersible) tablets, using lyophilization techniques.
The company has around 200 employees with teams focused on quality control, materials technology, contract manufacturing, quality assurance, engineering, logistics, safety and environment, and production.
Neuraxpharm Pharmaceuticals has a long history of successfully developing dossiers of generic and specialised pharmaceuticals that meet the latest high regulatory standards. Those dossiers can be licensed from Neuraxpharm Pharmaceuticals, including FDFs with customised artwork designed for specific market needs.
Neuraxpharm Pharmaceuticals has international authorisation for tablets, capsules, powders and injectables.
Successful internal/external audits
High regulatory performance
More than 125 granted patents in the most important countries worldwide
More than 220 dossiers (FDF) submitted to regulatory agencies of different territories